| 
		Bacteria with antibiotic resistant genes discovered in Antarctica, 
		scientists say
		 Send a link to a friend 
		
		 [May 26, 2022] 
		SANTIAGO (Reuters) - Bacteria in 
		Antarctica have been discovered with genes that give them natural 
		antibiotic and antimicrobial resistance and have the potential to spread 
		out of the polar regions, according to scientists in Chile. 
 Andres Marcoleta, a researcher from the University of Chile who headed 
		the study in the Science of the Total Environment journal in March, said 
		that these "superpowers" which evolved to resist extreme conditions are 
		contained in mobile DNA fragments that can easily be transferred to 
		other bacteria.
 
 "We know that the soils of the Antarctic Peninsula, one of the polar 
		areas most impacted by melting ice, host a great diversity of bacteria," 
		Marcoleta said. "And that some of them constitute a potential source of 
		ancestral genes that confer resistance to antibiotics."
 
 Scientists from the University of Chile collected several samples from 
		the Antarctic Peninsula from 2017 to 2019.
 
 "It is worth asking whether climate change could have an impact on the 
		occurrence of infectious diseases," Marcoleta said.
 
 "In a possible scenario, these genes could leave this reservoir and 
		promote the emergence and proliferation of infectious diseases."
 
		[to top of second column] | 
            
			 
            
			Scientists from the University of Chile work on a laptop as they 
			check organic material looking for a bacteria discovered in 
			Antarctica, May 2, 2019. Courtesy of University of Chile/Handout via 
			REUTERS 
            
			
			
			 Researchers found that the 
			Pseudomonas bacteria, one of the predominant bacteria groups in the 
			Antarctic Peninsula, are not pathogenic but can be a source of 
			'resistance genes', which are not stopped by common disinfectants 
			such as copper, chlorine or quaternary ammonium.
 However, the other kind of bacteria they researched, Polaromonas 
			bacteria, does have the "potential to inactivate beta-lactam type 
			antibiotics, which are essential for the treatment of different 
			infections," said Marcoleta.
 
 (Reporting by Fabian Cambero; Writing by Alexander Villegas; Editing 
			by Rosalba O'Brien)
 
 [© 2022 Thomson Reuters. All rights 
				reserved.]  This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content.
 |